03.01.2022
Versantis, a clinical-stage biotechnology company developing novel therapies for orphan liver and pediatric diseases, appointed Mark J. Fitzpatrick as Chief Executive Officer and member of the board of directors.
22.12.2021
In February 2022, ten Swiss technology startups will attend the annual Mobile World Congress as part of the week-long venture leaders roadshow. The program aims to introduce innovative mobile startups from Switzerland to international investors and telecom industry leaders. One of those companies will be the Adresta AG.
03.12.2021
The clinical-stage startup aims to minimise post-surgical complications in medical implants. Proceeds from its CHF 5.2 series B investment CHF 0.9 Million non-dilutive funding will support the company in obtaining the FDA and CE mark approval for its product portfolio, beginning with the Hylomate.
27.10.2021
Yokoy Group AG has raised about $26 million in a funding round led by Left Lane Capital, with participation from Balderton Capital, the Zurich-based firm said in an emailed statement.
The funds will be used to expand in Europe and the U.S., Chief Executive Officer Philippe Sahli said.
09.09.2021
At the 11th edition of the TOP 100 Swiss Startup Award Planted Foods (1st), a resident of Technopark Zurich, CUTISS (2nd), and 9T Labs (3rd) were the top picks of the expert jury. A selected audience of startups, investors, and key partners of the TOP 100 were present at the event, held at the newly renovated startup space in Schlieren.